We work with innovators of biotech, healthcare, science, sustainability, and advanced technology
CureLab Oncology submits patent for COVID therapeutic ahead of Phase I clinical trials
For patients who have contracted COVID, CureLab Oncology intends to determine how Elenagen can be used to reduce mortality and life-threatening complications, and to shorten time to recovery.